| dc.date.accessioned | 2018-12-11T11:07:38Z | |
| dc.date.available | 2018-12-11T11:07:38Z | |
| dc.identifier.citation | [2019] ZACC 41 | |
| dc.identifier.citation | 2020 (1) SA 327 (CC) | |
| dc.identifier.citation | 2020 (1) BCLR 1 (CC) | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12144/36586 | |
| dc.title | Ascendis Animal Health (Pty) Limited v Merck Sharpe Dohme Corporation and Others | en_US |
| dc.identifier.casenumber | CCT212/18 | |
| dc.date.hearing | 9 May 2019 | |
| dc.contributor.judge | The Court | |
| dc.contributor.judge | Khampepe J separate judgment | |
| dc.contributor.judge | Cameron J separate judgment | |
| dc.date.judgment | 24 October 2019 | |
| dc.link.judgment | https://collections.concourt.org.za/bitstream/handle/20.500.12144/36586/Full%20judgment%20Official%20version%2024%20October%202019.pdf?sequence=29&isAllowed=y | |
| dc.concourt.synopsis | Patents Act 57 of 1978 — section 61 — causes of action — res judicata — issue estoppel — bifurcated proceedings — amendment of pleas | |
| dc.concourt.casehistory | Application for leave to appeal against the judgment and order of the Commissioner of Patents in the Pretoria High Court: Cipla Agrimed (Pty) Ltd v Merck Sharo Dohme Group and Another (1998/10975) [2014] ZACCP 5 (11 March 2014). The SCA dismissed the application for leave to appeal: Merck Sharpe Dohme Group v Cipla Agrimed (Pty) Ltd (20282/2014) [2015] ZASCA 175; 2016 (3) SA 22 (SCA) (27 November 2015). |